Завершено
Фаза III
Россия
Tapentadol Extended Release; Matching Placebo after Tapentadol in the Titration Phase.; Morphine Sulphate Controlled Release · Grünenthal GmbH
A Randomized Withdrawal, Active- and Placebo-controlled, Double-blind, Multi-center Phase III Trial Assessing Safety and Efficacy of Oral CG5503 (Tapentadol) PR* in Subjects With Moderate to Severe Chronic Malignant Tumor-related Pain